Quarterly report pursuant to Section 13 or 15(d)

Incentive and Non-statutory Stock Option Plan - Schedule of Common Stock Purchase Options and Warrants (Details)

v3.5.0.2
Incentive and Non-statutory Stock Option Plan - Schedule of Common Stock Purchase Options and Warrants (Details)
 3 Months Ended
Sep. 30, 2016
USD ($)
$ / shares
shares
Warrants [Member]  
Number of shares, outstanding and exercisable beginning 163,124
Number of shares, granted
Number of shares, exercised
Number of shares, expired / cancelled (152,049)
Number of shares, outstanding and exercisable ending 11,075
Weighted average exercise price, outstanding and exercisable beginning | $ / shares $ 7.29
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, expired / cancelled | $ / shares 7.46
Weighted average exercise price, outstanding and exercisable ending | $ / shares $ 5.00
Weighted average remaining contractual life, outstanding and exercisable 2 months 23 days
Weighted average remaining contractual life, outstanding and exercisable 5 months 5 days
Aggregated intrinsic value, outstanding and exercisable | $ $ 9,303
Aggregated intrinsic value, outstanding and exercisable | $ $ 13,955
Options [Member]  
Number of shares, outstanding and exercisable beginning 610,133
Number of shares, granted 20,315
Number of shares, exercised (20,315)
Number of shares, expired / cancelled
Number of shares, outstanding and exercisable ending 610,133
Weighted average exercise price, outstanding and exercisable beginning | $ / shares $ 4.90
Weighted average exercise price, granted | $ / shares 4.75
Weighted average exercise price, exercised | $ / shares 4.75
Weighted average exercise price, expired / cancelled | $ / shares $ 4.90
Weighted average remaining contractual life, outstanding and exercisable 11 months 27 days
Weighted average remaining contractual life, outstanding and exercisable 8 months 27 days
Aggregated intrinsic value, outstanding and exercisable | $ $ 799,030
Aggregated intrinsic value, outstanding and exercisable | $ $ 1,013,097